Elanco

But there's no question that that's, am I going to go a branded or a generic? I'm probably going to start to shift to the generic.

And then I put on top of that their trio, some Perico, I think it is, is seeing a fair amount of competition from Elanco.

It imploded earlier this year.

Elanco was the spin out.

A number of years ago, I think that was Pfizer.

And so, but the, yeah, so seeing some competition there and Merck, ironically, though, is number three.

It's hard to turn down.

no i appreciate your call out on manufacturing and so you know we are very intentionally make making investments uh to make sure that uh that we call under uh the title catalyze indiana which is a cross company and and university initiative that brings Lilly and Elanco and Corteva and Notre Dame and IU and Purdue.

And the vision there is that we want to establish Indiana as a place where the next generation platform technologies that enables the onshoring and reshoring of manufacturing to the United States so that that can happen.

Because right now, a lot of that right now, as you know, has gone over to China.

Looking forward to the conversation today.

Uh, Kelly, uh, Dr. Kelly Mitchell, she's with Elanco Animal Health, and she was a moderator for a session today here at the Tri-State Nutrition Conference.

Uh, Kelly, tell us a little bit about yourself.

Thanks.

With Dr. Jeff Ferkins.

Um, I lived in Ohio for about seven years.

When I finished my PhD in 2022, I started with Elanco, was still in Ohio, and then I was telling the guys before the podcast started that, you know, it's a black hole in California.

There's a lot of cows in it.

There's a new product that's been registered and is now available called Xenrelia.

So Xenrelia is a new product by Elanco.

It's a JAK inhibitor, so same family of drugs as Apoquel.

And I think it's going to be another great tool to have in our little toolbox for dermatology patients.

We've got Purdue here now, R1 designation.

What excites you about that? The impact that that could have coupled with? this initiative around bio heartland, which then kind of spawns into, you think about human plant animal, you know, so we have, you know, Corteva and Elanco.

And, and then my question got so long, I think I forgot the third component, but like, what, what excites you about these assets that we have here in Indiana? And then in this 10 mile radius from where we're sitting right now, that could really help maybe advance things beyond our wildest imaginations five or 10 years ago.

Yeah, I think there's maybe two parts to that.

Our freshmen tend to do what I would call barn internships, so farm, ranch, or getting their vet hours in if they're on the pre-vet track, maybe back home.

And then they kind of move into companies maybe on the pharmaceutical side or on the nutrition side, companies like Cargill or Merck or Elanco Animal Health or Purina.

And that's going to be how they kind of progress through that last internship to be a little bit more, I would say, corporate or leading to all encompassing where they have a little bit more maturity and they've had a few more classes under their belt as well.

That could maybe just be the end of the show right there because holy cow, you really did hit the nail on the head.

They have their CPR and first aid license.

Our vet students have a certification through Elanco and they also have a fear-free certification, which is really, really looked highly upon in the vet world.

Our dental assistant students have taken the radiation health and safety exam.

And so they are able to go in and be dental assistants and kind of work their way up from there if that's what they choose to do.

They deployed an agent called Sidekick and generated $27.9 million in value.

And then there's Elanco generating a $1.9 million ROI simply by automating pharmacovigilance.

That Elanco example is so critical for understanding the real mechanism of ROI here.

How so?

Well, pharmacovigilance requires parsing massive, massive volumes of complex medical literature and adverse event reports to ensure drug safety.